IMPL

Impel Neuropharma Inc (IMPL)

US
$ 0.84450%

Price Chart

Key Statistics

Market Cap
$ 5.76M
P/E Ratio
0.00
Revenue (TTM)
$ 20.99M
Volume
5.97M
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.17

Technicals

50-Day MA
0.3116
200-Day MA
0.9332
52 Week High
N/A
52 Week Low
N/A

About IMPL

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in th.

Employees
160
Headquarters
Seattle, WA
CEO
Mr. Adrian Adams

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg